KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT: 2015-2024

Historic EBT for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $475.9 million.

  • Medpace Holdings' EBT rose 20.26% to $142.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $519.4 million, marking a year-over-year increase of 20.03%. This contributed to the annual value of $475.9 million for FY2024, which is 41.78% up from last year.
  • As of FY2024, Medpace Holdings' EBT stood at $475.9 million, which was up 41.78% from $335.7 million recorded in FY2023.
  • In the past 5 years, Medpace Holdings' EBT registered a high of $475.9 million during FY2024, and its lowest value of $168.5 million during FY2020.
  • Its 3-year average for EBT is $364.8 million, with a median of $335.7 million in 2023.
  • Data for Medpace Holdings' EBT shows a peak YoY soared of 41.78% (in 2024) over the last 5 years.
  • Over the past 5 years, Medpace Holdings' EBT (Yearly) stood at $168.5 million in 2020, then climbed by 19.77% to $201.9 million in 2021, then surged by 40.13% to $282.9 million in 2022, then increased by 18.67% to $335.7 million in 2023, then soared by 41.78% to $475.9 million in 2024.